Instil Bio, Inc. (TIL) stock
TILNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$5.40−0.35 (-6.09%)
Close on Nov 17, 2026Market cap $36.62MP/E –Yield –
Instil Bio revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Instil Bio's revenue for the twelve months ending Dec 31, 2021 was $0, down 100.0% year over year. For fiscal 2021 it was $0, down 100.0% from the year before.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | $0 | -100.0% |
| FY2020 | Dec 31, 2020 | $138.00K | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2021 | Dec 31, 2021 | $0 | – |
| Q3 FY2021 | Sep 30, 2021 | $0 | -100.0% |
| Q2 FY2021 | Jun 30, 2021 | $0 | -100.0% |
| Q1 FY2021 | Mar 31, 2021 | $0 | -100.0% |
| Q4 FY2020 | Dec 31, 2020 | $0 | – |
| Q3 FY2020 | Sep 30, 2020 | $52.00K | – |
| Q2 FY2020 | Jun 30, 2020 | $42.00K | – |
| Q1 FY2020 | Mar 31, 2020 | $44.00K | – |
See a number that looks wrong?